jonexa
genzyme corporation - רופא - temporary replacement and supplement of synovial fluid
urology products of mentor corporation
a.m.i. technologies, ltd. - רופא
seprafilm
genzyme corporation - רופא - an adjunct in abdominal, pelvic, and thoracic surgery for reducing the incidence, extent and severity of postoperative adhesions at the site of placement, and to reduce adhesive small bowel obstruction when placed in the abdomen.
אונג'נטיס 50 מג
truemed ltd, israel - opicapone - קפסולה קשיחה - opicapone 50 mg - opicapone
זביניקס 200 מג
truemed ltd, israel - eslicarbazepine acetate - טבליה - eslicarbazepine acetate 200 mg - eslicarbazepine
זביניקס 800 מג
truemed ltd, israel - eslicarbazepine acetate - טבליה - eslicarbazepine acetate 800 mg - eslicarbazepine
לוטמקס תרחיף
abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po
זפוסיה 0.23 מג
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.23 mg - ozanimod